STRW 📈 Strawberry Fields REIT - Overview
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock •
STRW: Nursing Homes, Assisted Living Facilities, Hospitals
Strawberry Fields REIT, Inc., is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company's portfolio includes 109 healthcare facilities with an aggregate of 12,449 bed, located throughout the states of Arkansas, Illinois, Indiana, Kentucky, Michigan, Ohio, Oklahoma, Tennessee and Texas. The 109 healthcare facilities comprise 99 skilled nursing facilities, eight assisted living facilities, and two long-term acute care hospitals. Web URL: https://www.strawberryfieldsreit.com
Additional Sources for STRW Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
STRW Stock Overview
Market Cap in USD | 669m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Real Estate Development |
IPO / Inception | 2022-09-21 |
STRW Stock Ratings
Growth 5y | 39.7% |
Fundamental | 25.2% |
Dividend | 64.1% |
Rel. Strength Industry | 1216 |
Analysts | 4.5/5 |
Fair Price Momentum | 10.71 USD |
Fair Price DCF | 101.89 USD |
STRW Dividends
Dividend Yield 12m | 3.57% |
Yield on Cost 5y | 4.32% |
Annual Growth 5y | 112.13% |
Payout Consistency | 100.0% |
STRW Growth Ratios
Growth Correlation 3m | -41.5% |
Growth Correlation 12m | 84.8% |
Growth Correlation 5y | 70.5% |
CAGR 5y | 9.51% |
CAGR/Mean DD 5y | 0.30 |
Sharpe Ratio 12m | 0.91 |
Alpha | 40.07 |
Beta | -0.04 |
Volatility | 55.18% |
Current Volume | 566k |
Average Volume 20d | 262.4k |
What is the price of STRW stocks?
As of December 22, 2024, the stock is trading at USD 10.65 with a total of 566,000 shares traded.
Over the past week, the price has changed by -0.29%, over one month by -12.52%, over three months by -4.70% and over the past year by +42.65%.
As of December 22, 2024, the stock is trading at USD 10.65 with a total of 566,000 shares traded.
Over the past week, the price has changed by -0.29%, over one month by -12.52%, over three months by -4.70% and over the past year by +42.65%.
Is Strawberry Fields REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Strawberry Fields REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.22 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STRW as of December 2024 is 10.71. This means that STRW is currently overvalued and has a potential downside of 0.56%.
Neither. Based on ValueRay Fundamental Analyses, Strawberry Fields REIT is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.22 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STRW as of December 2024 is 10.71. This means that STRW is currently overvalued and has a potential downside of 0.56%.
Is STRW a buy, sell or hold?
Strawberry Fields REIT has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy STRW.
Strawberry Fields REIT has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy STRW.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for STRW stock price target?
According to ValueRays Forecast Model, STRW Strawberry Fields REIT will be worth about 11.6 in December 2025. The stock is currently trading at 10.65. This means that the stock has a potential upside of +8.54%.
According to ValueRays Forecast Model, STRW Strawberry Fields REIT will be worth about 11.6 in December 2025. The stock is currently trading at 10.65. This means that the stock has a potential upside of +8.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14 | 31.5% |
Analysts Target Price | 10 | -6.1% |
ValueRay Target Price | 11.6 | 8.5% |